High-risk neuroblastoma

What changed: High-risk neuroblastoma

Indication page →

Every dated change on the records linked to High-risk neuroblastoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone8This record1

FollowWatch this record and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordHigh-risk neuroblastoma
Facts on this page last checked
When this page itself was last checked or edited.

2023 · 1

2023MilestoneHigh-risk neuroblastoma
Eflornithine approved as maintenance on an external-control comparison; GD2 CAR T-cells produce remissions in relapsed disease
A milestone in how this cancer is treated.

2020 · 1

2020MilestoneHigh-risk neuroblastoma
Naxitamab granted accelerated approval for relapsed or refractory bone or marrow disease
A milestone in how this cancer is treated.

2019 · 1

2019MilestoneHigh-risk neuroblastoma
ANBL0532: tandem transplant beats single transplant
A milestone in how this cancer is treated.

2017 · 1

2017MilestoneHigh-risk neuroblastoma
HR-NBL1: busulfan-melphalan beats carboplatin-etoposide-melphalan
A milestone in how this cancer is treated.

2015 · 1

2015MilestoneHigh-risk neuroblastoma
Dinutuximab approved for high-risk neuroblastoma
A milestone in how this cancer is treated.

2010 · 1

2010MilestoneHigh-risk neuroblastoma
ANBL0032: anti-GD2 antibody with GM-CSF and interleukin-2 raises two-year event-free survival from 46 to 66 percent
A milestone in how this cancer is treated.

1999 · 1

1999MilestoneHigh-risk neuroblastoma
CCG-3891: myeloablative therapy with autologous rescue and 13-cis-retinoic acid each improve event-free survival
A milestone in how this cancer is treated.

1985 · 1

1985Milestone131I-MIBG (iobenguane I-131) therapy
Iodine-131 MIBG therapy first given for neuroblastoma
A milestone in how this cancer is treated.